丰川资本 (FC Capital) is a China-based private equity firm focused on investing in the bio-medical and healthcare industries. Established in 2015, the firm specializes in cross-border investments and aims to support the development of innovative and growth-oriented companies in the biopharmaceutical, medical device, medical services, and health consumption sectors.
Focus Areas
Investment Types
Notable Investments
